Literature DB >> 334625

Treatment of chronic active hepatitis. An analysis of three controlled trials.

E C Wright, L B Seeff, P D Berk, A Jones, P H Plotz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 334625

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

Review 1.  Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use.

Authors:  A R Tanner; L W Powell
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

Review 2.  Chronic hepatitis: a review.

Authors:  R A Bradbear
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

Review 3.  Historical treatment of chronic hepatitis B and chronic hepatitis C.

Authors:  P Ferenci
Journal:  Gut       Date:  1993       Impact factor: 23.059

4.  Chronic hepatitis. Aetiology and current management.

Authors:  W G Cooksley; R A Bradbear; J W Halliday; L W Powell
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

5.  Chronic active hepatitis (CAH): criteria for treatment.

Authors:  E Ascione; C Linardi
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

6.  Abnormal aminopyrine metabolism in patients with chronic hepatitis.

Authors:  G W Hepner; E Piken; J Lechago
Journal:  West J Med       Date:  1981-05

7.  Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen.

Authors:  J J Vallotton; P C Frei
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

8.  Chronic active hepatitis in childhood with detection of liver-pancreas-specific autoantibodies.

Authors:  M Teufel; K H Niessen; P A Berg
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

9.  Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis.

Authors:  L D Jackson; E Song
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

10.  Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.

Authors:  A P Kirk; S Jain; S Pocock; H C Thomas; S Sherlock
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.